Your browser doesn't support javascript.
loading
Body Composition Is an Independent Predictor of Outcome in Patients with Hepatocellular Carcinoma Treated with Sorafenib.
Labeur, Tim A; van Vugt, Jeroen L A; Ten Cate, David W G; Takkenberg, R Bart; IJzermans, Jan N M; Groot Koerkamp, Bas; de Man, Robert A; van Delden, Otto M; Eskens, Ferry A L M; Klümpen, Heinz-Josef.
Afiliação
  • Labeur TA; Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • van Vugt JLA; Department of Medical Oncology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
  • Ten Cate DWG; Department of Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Takkenberg RB; Department of Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • IJzermans JNM; Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
  • Groot Koerkamp B; Department of Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • de Man RA; Department of Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • van Delden OM; Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Eskens FALM; Department of Radiology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
  • Klümpen HJ; Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Liver Cancer ; 8(4): 255-270, 2019 Jul.
Article em En | MEDLINE | ID: mdl-31602369

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article